Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children.

Marion GrimaudJulie StarckMichael LevyClémence MaraisJudith ChareyreDiala KhraicheMarianne Leruez-VillePierre QuartierPierre Louis LégerGuillaume GeslainNada SemaanFlorence MoulinMatthieu BendavidSandrine JeanGéraldine PonceletSylvain RenolleauMehdi Oualha

Published in: Annals of intensive care (2020)

Acute myocarditis with intense systemic inflammation and atypical Kawasaki disease is an emerging severe pediatric disease following SARS-CoV-2 infection. Early recognition of this disease is needed and referral to an expert center is recommended. A delayed and inappropriate host immunological response is suspected. While underlying mechanisms remain unclear, further investigations are required to target an optimal treatment.

Keyphrases

liver failure
drug induced
respiratory failure
primary care
oxidative stress
pulmonary embolism
intensive care unit
clinical practice
smoking cessation